Snowdome Foundation

15/06/2026

We are proud to share the Snowdome Foundation 2025 Annual Review.

This year's Review highlights the impact made possible through the generosity of our supporters, showcasing the research breakthroughs, collaborations and innovations helping to accelerate better treatments and outcomes for people living with blood cancer.

From cutting-edge research to expanding access to next-generation therapies, every milestone reflects our commitment to making hope real for patients and their families.

Download the 2025 Annual Review here: https://lnkd.in/gzP_Vrq8

Thank you to everyone who helped bring this publication to life, including Grant Rutherford and the Taboo Group for their creativity and ongoing support.

❄️ As 30 June approaches, please consider a tax-deductible donation to Snowdome to drive the next wave of blood cancer research and treatment breakthroughs. ❄️

Please donate: https://lnkd.in/g6Zq3SwJ

05/06/2026

*Reminder*

Applications close 10 am AEST Monday 15th June 2026.

Two Fellowship Opportunities: the Chloe Rutherford Paediatric Haematology Fellowship and the John Tandy Myeloma Haematology Fellowship.

Each offers up to $400,000 in funding over three years to support cutting-edge translational research, with a strong focus on accelerating clinical impact for patients with blood cancer.

For more information and to apply, please visit the 'Grants' section on our website via the link below:

🔗 https://snowdome.org.au/grants/

28/05/2026

Today, on World Blood Cancer Day, we recognise the growing impact of blood cancer in Australia and the urgent need for continued research and innovation.

At Snowdome, we transform outcomes for Australians with blood cancer by championing research, bold ideas, and cutting-edge treatments.

12/05/2026

Today, and every day, we celebrate the incredible nurses who care for patients with compassion, expertise and dedication.

In haematology and oncology, nurses play a vital role in supporting patients through diagnosis, treatment and recovery - providing not only clinical care, but also reassurance, advocacy and human connection during some of life’s most challenging moments.

Featured is Epworth Freemasons’ Specialist Haematology Nurse Coordinator – Cell Therapy, Mary Sharlyn Benemerito, whose work supports patients and teams in delivering safe, coordinated care throughout their treatment journey.

Happy ! Thank you to all nurses for the extraordinary work you do. 💙 ❄️

06/05/2026

The Snowdome Foundation applauds a significant milestone for Australian patients living with multiple myeloma.

The announcement of government-funded access to the CAR T-cell therapy Carvykti, as a fourth-line treatment, is a major step forward in improving access to life-changing therapies.

This milestone is the result of tireless advocacy by patients, clinicians, and the broader community, who have worked to ensure these breakthrough treatments are within reach. Patients who were once waiting are now willing, ready - and able - to access this therapy.

While this is a significant step, it’s also a reminder of the importance of continuing this momentum. Access, equity, and earlier availability of innovative treatments like CAR T-cell therapy remain critical.

The Snowdome Foundation remains committed to advocating for equitable access to next-generation therapies for all Australians living with blood cancer.

Please watch the 7NEWS story:
🔗 https://www.youtube.com/watch?v=b2KQNhUAYw4

A tireless campaign by high-profile cancer patients has won a major victory. They've helped persuade the government to pay for groundbreaking myeloma treatme...

28/04/2026

Thank you to Snowdome Patron Sam Neill, advocate Geoffrey Nyssen, and Professor Miles Prince for standing with Snowdome to speak up for something that matters deeply.

CAR T-cell therapy is transforming outcomes for people with blood cancer, offering hope where there was once very little.

Together, they are advocating for this treatment to be more accessible, so every Australian who needs it has the same chance to benefit, no matter their circumstances or where they live.

At Snowdome, we remain committed to pushing for faster, fairer access to CAR T-cell therapy in Australia and to helping bring these breakthroughs closer to home.

Watch the 7NEWS story: https://lnkd.in/ggP5SxTN

26/04/2026

The Snowdome Foundation is inviting applications for two Fellowships: the Chloe Rutherford Paediatric Haematology Fellowship and the John Tandy Myeloma Haematology Fellowship.

Each offers up to $400,000 in funding over three years to support cutting-edge translational research, with a strong focus on accelerating clinical impact for patients with blood cancer.

For more information and to apply, please visit our website:

🔗https://lnkd.in/gZMpeRn9

Applications close 10am AEST Monday 15th June 2026.

23/04/2026

On World Laboratory Day, we recognise the people behind the scenes driving discovery and innovation in blood cancer research.

At the Epworth Centre for Immunotherapies and Snowdome Laboratories (ECISL), teams are advancing world-class care through immunotherapies, clinical trials and research, helping to improve outcomes for patients with blood cancer.

Established through a partnership between the Epworth Medical Foundation and the Snowdome Foundation, ECISL is proudly 100 per cent donor funded and supports the development of next-generation treatments, including CAR T-cell therapy.

Today, we acknowledge the vital work happening in our laboratories and the impact it is making for patients.

20/04/2026

The Snowdome Foundation is proud to support research led by Dr Paul Yeh at Monash University and Monash Health.

Dr Yeh is a clinician-researcher who combines patient care with leading the Blood Cancer Biomarkers Laboratory at Monash University. His work has driven the development of diagnostic tests now used in Australian hospitals, reflecting a strong track record of translating research into real-world impact.

Dr Yeh’s research will focus on identifying early, symptom-free changes in the blood that may signal the risk of aggressive cancers. By enabling earlier detection and potential prevention, this work aims to identify at-risk individuals before blood cancer takes hold.

Read more: 🔗 https://bit.ly/4mKoU5W

09/04/2026

Snowdome Foundation is proud to support a world‑first study through the GURNER™ Snowdome Immunotherapy Fellowship.

In collaboration with Epworth, this research is exploring how the gut microbiome may influence treatment outcomes in multiple myeloma, helping to advance more personalised and effective care for patients.

To learn more about this important work, please see the post below.